Back
Alpine Income Property Trust Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
38
PINE
Alpine Income Property Trust
Last Price:
$16.62
Seasonality Move:
6.96%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
38
Alpine Income Property Trust (PINE)
is a Sell
Is Alpine Income Property Trust a Buy, Sell or Hold?
-
The current Alpine Income Property Trust [PINE] share price is $16.61. The Score for PINE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
PINE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PINE Stock Price Chart
What is Alpine Income Property Trust's stock price today?
-
The Alpine Income Property Trust share price today is $16.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PINE is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $268.46The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
PINE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 55.61 | Buy |
Chaikin Money Flow: | 25560 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.19 - 16.59) | Buy |
Bollinger Bands (100): | (16.3 - 17.56) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.41 | Buy |
Relative Strength Index (14 RSI): | 55.64 | Buy |
Chaikin Money Flow: | 78938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.82 - 268.04) | Buy |
Bollinger Bands (100): | (240.65 - 270.25) | Buy |
PINE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.43 | Buy |
20-day SMA: | 16.36 | Buy |
50-day SMA: | 16.51 | Buy |
200-day SMA: | 17.04 | Sell |
8-day EMA: | 16.44 | Buy |
20-day EMA: | 16.4 | Buy |
50-day EMA: | 16.54 | Buy |
200-day EMA: | 16.82 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 271.33 | Sell |
20-day SMA: | 255.41 | Buy |
50-day SMA: | 259.88 | Buy |
200-day SMA: | 253.94 | Buy |
8-day EMA: | 268.64 | Sell |
20-day EMA: | 261.32 | Buy |
50-day EMA: | 257.88 | Buy |
200-day EMA: | 244.57 | Buy |
Alpine Income Property Trust Earnings Growth & PINE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.01 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.06 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Alpine Income Property Trust Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |